Is compounded semaglutide as effective as Wegovy or Ozempic
Wellstar Cardio-Oncology teams partner with patients and families to understand risks and create a personalized plan
The comparatively greater cellularity of the melanotic spot on the lip may explain the lesions reluctance to respond to ablative treatments, unlike lentigines, which respond better
For most people using GLP-1 receptor agonists, the findings do not warrant stopping treatment
PAMPs) but also damaged tissues (damage-associated molecular patterns
Here are 8 potential reasons why not to prescribe Lixisenatide: 1- this is only one small study and only one dose was tested, 2- Lixisenatide is not currently available at pharmacies, 3- the weight loss associated with this GLP-1 is not desirable in many cases of Parkinsons disease where weight loss is an issue, 4- non-motor outcomes did not change as in other trials, and this will need to be better explained